[{"type": "title", "data": "ANES Labour REMifentanil Patient Controlled Analgesia (PCA) (Module)"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "Restricted to Department of Anesthesiology", "value": ""}, {"type": "note", "data": "Ensure BC Women's Hospital consent form completed", "value": ""}, {"type": "note", "data": "Labour REMifentanil Patient Controlled Analgesia Protocol", "value": ""}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "Ensure REMifentanil PCA Patient Information Sheet is given to the patient, available through online resource library"}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "Ensure BC Women's Hospital consent form completed"}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "Call Pediatrics (to be present at delivery and informed of REMifentanil PCA use)"}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "Do NOT give any Opioids, CNS Depressants, and other analgesics unless approved by Anesthesiology, Family Practice Maternity Service Group 2 or Perinatal Addictions Service"}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "Continuous nursing presence required while REMifentanil PCA connected to patients and for 15 minute post cannula removal"}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "Upon discontinuation of REMifentanil PCA, record IV removal in nursing record"}, {"type": "order", "data": "Notify Treating Provider", "value": "checked"}, {"type": "sentence", "data": "If inadequate analgesia or other problems with fentanyl PCA"}, {"type": "note", "data": "Monitoring Orders are for Inpatient Ward", "value": ""}, {"type": "order", "data": "Vital Signs", "value": "checked"}, {"type": "sentence", "data": "Prior to initiation then q5min for 20 minute, then q30min for duration of PCA use"}, {"type": "order", "data": "Pulse Oximetry", "value": "checked"}, {"type": "sentence", "data": "Prior to initiation then q5min for 20 minute, then q30min for duration of PCA use"}, {"type": "order", "data": "Oximetry - Continuous", "value": "checked"}, {"type": "sentence", "data": "T;N, On initiation of REMifentanil PCA and for 15 minute post PCA IV cannula removal"}, {"type": "order", "data": "Sedation Assessment", "value": "checked"}, {"type": "sentence", "data": "Prior to initiation then q5min for 20 minute, then q30min for duration of PCA use"}, {"type": "order", "data": "Pain Assessment", "value": "checked"}, {"type": "sentence", "data": "Prior to initiation then q5min for 20 minute, then q30min for duration of PCA use"}, {"type": "order", "data": "Respiratory Rate", "value": "checked"}, {"type": "sentence", "data": "Prior to initiation then q5min for 20 minute, then q30min for duration of PCA use"}, {"type": "note", "data": "Following Clinician / Provider Bolus Dose: Change", "value": ""}, {"type": "order", "data": "Vital Signs", "value": "checked"}, {"type": "sentence", "data": "q5min for 20 minute, then q30min for duration of PCA use"}, {"type": "order", "data": "Pulse Oximetry", "value": "checked"}, {"type": "sentence", "data": "q5min for 20 minute, then q30min for duration of PCA use"}, {"type": "order", "data": "Respiratory Rate", "value": "checked"}, {"type": "sentence", "data": "q5min for 20 minute, then q30min for duration of PCA use"}, {"type": "order", "data": "Pain Assessment", "value": "checked"}, {"type": "sentence", "data": "q5min for 20 minute, then q30min for duration of PCA use"}, {"type": "order", "data": "Sedation Assessment", "value": "checked"}, {"type": "sentence", "data": "q5min for 20 minute, then q30min for duration of PCA use"}, {"type": "order", "data": "Insert Peripheral IV Catheter", "value": "checked"}, {"type": "sentence", "data": "T;N, If not already inserted"}, {"type": "order", "data": "Insert Peripheral IV Catheter", "value": "checked"}, {"type": "sentence", "data": "T;N, insert second PIV dedicated for REMifentanil PCA use only"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Anesthesiologist must be present for first 15 minute of PCA initiation and for 10 minutes after any dose change", "value": ""}, {"type": "note", "data": "For patients less than 60 kg: 20 mcg starting dose, 2 minute lockout interval, no background infusion\nFor patients 60 to 80 kg: 30 mcg starting dose, 2 minute lockout interval, no background infusion\nFor patients greater than 80 kg: 40 mcg starting dose, 2 minute lockout interval, no background infusion", "value": ""}, {"type": "note", "data": "PCA dose changes:\n- Only increments of 10 mcg are available\n- Minimum bolus dose: 10 mcg\n- Maximum bolus dose: 50 mcg", "value": ""}, {"type": "note", "data": "REMifentanil PCA Initiation Checklist", "value": ""}, {"type": "order", "data": "REMifentanil 25 mcg/mL PCA (CADD)- total volume", "value": ""}, {"type": "sentence", "data": "Therapy Type: IV PCA, Infusion Mode: PCA dose only, 20 mcg PCA dose, 2 min lockout interval, 1-hour limit: 600 mcg, pump type: CADD, IV"}, {"type": "sentence", "data": "Therapy Type: IV PCA, Infusion Mode: PCA dose only, 30 mcg PCA dose, 2 min lockout interval, 1-hour limit: 600 mcg, pump type: CADD, IV"}, {"type": "sentence", "data": "Therapy Type: IV PCA, Infusion Mode: PCA dose only, 40 mcg PCA dose, 2 min lockout interval, 1-hour limit: 600 mcg, pump type: CADD, IV"}, {"type": "order", "data": "Nitrous Oxide Gas Administration", "value": "checked"}, {"type": "sentence", "data": "PRN, During REMifentanil PCA initiation"}, {"type": "order", "data": "ondansetron", "value": ""}, {"type": "sentence", "data": "4 mg, IV, q8h, PRN nausea or vomiting, drug form: inj"}, {"type": "order", "data": "dimenhyDRINATE PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 25 to 50 mg, IV, q4h, PRN nausea or vomiting, drug form: inj"}, {"type": "order", "data": "diphenhydrAMINE", "value": ""}, {"type": "sentence", "data": "25 mg, IV, q4h, PRN itching, drug form: inj"}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "Simultaneous administration of other opioids, tranquilizers, hypnotics or sedatives via IV or other routes will have a synergistic effect causing increased sedation and respiratory depression", "value": ""}, {"type": "order", "data": "naloxone", "value": "checked"}, {"type": "sentence", "data": "0.1 mg, IV, q2min, PRN reverse opioid effect, drug form: inj"}, {"type": "category", "data": "Respiratory"}, {"type": "order", "data": "Oxygen Therapy", "value": "checked"}, {"type": "sentence", "data": "Titrate O2 to keep SpO2 95% or greater"}, {"type": "order", "data": "Oxygen Therapy", "value": "checked"}, {"type": "sentence", "data": "10 L/min via facemask if naloxone administered"}, {"type": "category", "data": "Consults/Referrals"}, {"type": "note", "data": "Consider consultation with Pediatrics", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "Anesthesia Pain Service Following", "value": ""}, {"type": "sentence", "data": "T;N"}]
